Cargando…

Chondrosarcoma-from Molecular Pathology to Novel Therapies

SIMPLE SUMMARY: Chondrosarcoma (CHS) belongs to a broad group of sarcomas and is the second most frequent malignant bone tumor. Due to its resistance to chemo- and radiotherapy, treatment of this tumor is complicated and is mainly limited to surgery. In this review, we described the characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales: Zając, Agnieszka E., Kopeć, Sylwia, Szostakowski, Bartłomiej, Spałek, Mateusz J., Fiedorowicz, Michał, Bylina, Elżbieta, Filipowicz, Paulina, Szumera-Ciećkiewicz, Anna, Tysarowski, Andrzej, Czarnecka, Anna M., Rutkowski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155983/
https://www.ncbi.nlm.nih.gov/pubmed/34069269
http://dx.doi.org/10.3390/cancers13102390

Ejemplares similares